(Q34590985)

3 August 2017

0 references

1 reference

title

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction (English)

1 reference

3 August 2017

1 reference

Salim Daya

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

3 August 2017

published in

Fertility and Sterility

1 reference

3 August 2017

volume

77

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

711-714

1 reference

Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2903246-0

Bias in meta-analysis detected by a simple, graphical test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2903246-0

A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2903246-0

Publication bias in clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2903246-0

Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2903246-0

10.1016/S0015-0282(01)03246-0

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference